Elevated pulse pressure is associated with an increased risk of all-cause and cardiovascular death in patients on peritoneal dialysis (PD), according to a Canadian study.
Rosuvastatin therapy lowers LDL in hemodialysis (HD) patients but has no significant effect on cardiovascular events, researchers reported in The New England Journal of Medicine (2009;360:1395-1407).
Hyperuricemia increases the risk of death from any cause and from cardiovascular disease (CVD) in patients with CKD stages 3 to 4, according to a report in the American Journal of Kidney Diseases (2009; published online ahead of print).
Heart disease is significantly more prevalent in older white women with a history of kidney stones than in those who have never had a kidney stone, new findings suggest.
CHICAGO—Erectile dysfunction (ED) is associated with an increased risk of death from any cause and from cardiovascular disease (CVD), new findings show.
Hemodialysis patients with moderate to severe periodontal disease are five times more likely to die from cardiovascular disease (CVD) compared with those with mild or no periodontal disease, according to researchers.
NEW ORLEANS—Most heart failure patients with renal failure can be managed successfully with ACE inhibitors or angiotensin receptor blockers (ARBs), and the treatment is associated with better outcomes, said Virgina B. Thayer, MS, at the 2008 scientific sessions of the American Heart Association.
HOUSTON—Hemodialysis (HD) patients aged 70 years and older do not have more frequent or longer hospitalizations than younger HD patients overall, but the older patients may have a higher hospitalization rate due to cardiovascular disease (CVD), investigators concluded.